Special Issue "Cancer Molecules in Ovarian Cancer 2012"
Deadline for manuscript submissions: closed (30 June 2012)
Prof. Dr. Ie-Ming Shih (Website)
Department of Pathology, Faculty in Pathobiology PhD Graduate Program, Johns Hopkins University, School of Medicine, CRB-II, Rm 305, 1550 Orleans Street, Baltimore, Maryland 21231, USA
Fax: +1 410 502 7943
Interests: cancer pathogenesis; gene amplification; gene mutation; differential diagnosis; genome-wide analysis of human cancer
Ovarian cancer is a highly aggressive neoplastic disease in women. It is well accepted that identification and characterization of ovarian cancer-associated genes are fundamental toward elucidating its pathogenesis and providing new opportunity for cancer detection and therapy. Many investigators over the past several years have diligently applied several new technologies to study the molecular landscape of ovarian cancer. Importantly, the Cancer Genome Atlas (TCGA) project has recently deposited unprecedented amount of data on molecular characteristics of ovarian high-grade serous carcinoma. This special issue timely honors these new advances and cordially invites the publications of new cancer-associated molecules and the pathways that are important to understand the pathogenesis and provide new molecular landscape in designing targeted therapy in ovarian cancer. Specifically, we welcome the manuscripts that report molecules that are related to molecular etiology, biomarkers for detections and diagnosis, and molecular targets for new therapeutics. Manuscripts reporting analysis of the TCGA database and new revelation of molecular signatures pertaining to clinical outcome are specially encouraged to submit. Review articles that succinctly summarize recent advances in the fields as mentioned above are also very welcome.
Prof. Dr. Ie-Ming Shih
- ovarian cancer
- target therapy